MERSANA THERAPEUTICS INC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2016-03-01. The offering totals $35.5M, of which $10.1M was reported sold. Industry: Biotechnology.
Showing 25 of 48 people.
| Name | Role | Location |
|---|---|---|
| Michael J Kaufman | Executive Officer | New York, NY |
| Peter Park | Executive Officer | San Francisco, CA |
| Sara Nayeem | Director | Menlo Park, CA |
| Elaine Jones | Director | SOUTH SAN FRANCISCO, CA |
| Sara J Nayeem | Director | BOSTON, MA |
| C. Boyd Clarke | Director | Madison, WI |
| Thomas Beck | Director | Milwaukee, WI |
| David G Mott | Director | CAMBRIDGE, MA |
| Sara G Nayeem | Director | CAMBRIDGE, MA |
| David Mott | Director | Chevy Chase, MD |
| David Mott | Executive Officer | Chevy Chase, MD |
| TIMOTHY LOWINGER | Executive Officer | CAMBRIDGE, MA |
| ELAINE J JONES | Director | CAMBRIDGE, MA |
| THOMAS J BECK | Director | CAMBRIDGE, MA |
| ANNA PROTOPAPAS | Director | CAMBRIDGE, MA |
| ANNA PROTOPAPAS | Executive Officer | CAMBRIDGE, MA |
| EVA JACK | Executive Officer | CAMBRIDGE, MA |
| DONALD BERGSTROM | Executive Officer | CAMBRIDGE, MA |
| WAYNE J FOSTER | Executive Officer | CAMBRIDGE, MA |
| WAYNE FOSTER | Executive Officer | CAMBRIDGE, MA |
| Wayne B Foster | Executive Officer | Cambridge, MA |
| Nicholas G Bacopoulos | Director | Cambridge, MA |
| Nicholas G Bacopoulos | Executive Officer | Cambridge, MA |
| Timothy B Lowinger | Executive Officer | Cambridge, MA |
| Thomas G Beck | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2016-06-24 | D | $33.1M | $33.1M |
| 2015-03-03 | D | $35.5M | $10.1M |
| 2014-04-08 | D/A | $14.5M | $14.5M |
| 2013-10-09 | D | $14.5M | $5.0M |
| 2012-08-09 | D | $27.0M | $12.5M |
| 2012-04-18 | D/A | $10.0M | $10.0M |
| 2011-04-21 | D | $10.0M | $6.0M |
| 2010-02-26 | D | $3.5M | $2.5M |